CSIMarket
 


Accustem Sciences Inc   (ACUT)
Other Ticker:  
 

Accustem Sciences Inc 's Tangible Leverage Ratio

ACUT's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




ACUT Tangible Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter


Y / Y Tangible Equity Change - - - - -
Y / Y Total Liabilities Change - - - - -
Tangible Leverage Ratio MRQ 1.03 0.44 0.21 - -
Overall Ranking # 1905 # 0 # 0 # #
Seq. Tangible Equity Change -51.67 % -38.66 % - - -
Seq. Total Liabilities Change 12.79 % 30.35 % - - -



Tangible Leverage Ratio third quarter 2022 Comment
Due to net new borrowings of 12.79%, Tangible Leverage Ratio detoriated to 1.03, a new company high.

Within Major Pharmaceutical Preparations industry in the third quarter 2022, 334 other companies have achieved lower Tangible Leverage Ratio than Accustem Sciences Inc . While Tangible Leverage Ratio total ranking has deteriorated compare to the previous quarter from 0 to 1905.

Explain Tangible Leverage Ratio?
What is ACUT Market Share?
Tangible Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 335
Healthcare Sector # 687
Overall Market # 1905


Tangible Leverage Ratio Statistics
High Average Low
1.03 0.56 0.21
(Sep 30 2022)   (Mar 31 2022)




Financial Statements
Accustem Sciences Inc 's Tangible Equity $ 1 Millions Visit ACUT's Balance sheet
Accustem Sciences Inc 's Total Liabilities $ 1 Millions Visit ACUT's Balance sheet
Source of ACUT's Sales Visit ACUT's Sales by Geography


Cumulative Accustem Sciences Inc 's Tangible Leverage Ratio

ACUT's Tangible Leverage Ratio for the trailling 12 Months

ACUT Tangible Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter


Y / Y Tangible Equity TTM Growth - - - - -
Y / Y Total Liabilities TTM Growth - - - - -
Tangible Leverage Ratio TTM 0.41 0.3 0.21 - -
Total Ranking TTM # # # # #
Seq. Tangible Equity TTM Growth -51.67 % -38.66 % - - -
Seq. Total Liabilities TTM Growth 12.79 % 30.35 % - - -


TTM Tangible Leverage Ratio Comment
On the trailing twelve months basis Due to net new borrowings of 12.79%, Tangible Leverage Ratio improved to 0.41, above Accustem Sciences Inc 's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry ACUT recorded the lowest Tangible Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. 0.

Explain Tangible Leverage Ratio?
What is ACUT Market Share?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Within the Market # 0


TTM Tangible Leverage Ratio Statistics
High Average Low
0 0 0
 




Companies with similar Tangible Leverage Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Tangible Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Tangible Equity
Opko Health Inc   2.70 $ 595.717  Millions$ 220.433  Millions
Albireo Pharma inc   2.67 $ 221.151  Millions$ 82.811  Millions
G1 Therapeutics Inc   2.62 $ 120.608  Millions$ 45.965  Millions
Seres Therapeutics Inc   2.56 $ 172.913  Millions$ 67.585  Millions
Aveo Pharmaceuticals Inc   2.51 $ 72.388  Millions$ 28.845  Millions
Rockwell Medical inc   2.50 $ 38.050  Millions$ 15.215  Millions
Mersana Therapeutics inc   2.49 $ 224.621  Millions$ 90.229  Millions
Landec Corporation  2.40 $ 179.163  Millions$ 74.618  Millions
Plx Pharma Inc   2.40 $ 19.490  Millions$ 8.126  Millions
Spectrum Pharmaceuticals Inc   2.32 $ 83.077  Millions$ 35.852  Millions
Foghorn Therapeutics Inc   2.27 $ 55.268  Millions$ 24.323  Millions
Palatin Technologies Inc   2.27 $ 19.193  Millions$ 8.449  Millions
Cryoport inc   2.20 $ 474.418  Millions$ 216.123  Millions
Chembio Diagnostics Inc   2.17 $ 38.635  Millions$ 17.793  Millions
Effector Therapeutics Inc   2.17 $ 25.091  Millions$ 11.560  Millions
Axsome Therapeutics Inc   2.16 $ 181.596  Millions$ 84.197  Millions
9 Meters Biopharma Inc   2.13 $ 28.674  Millions$ 13.461  Millions
Qualigen Therapeutics Inc   2.09 $ 10.808  Millions$ 5.167  Millions
Oncotelic Therapeutics Inc   2.05 $ 16.050  Millions$ 7.844  Millions
Ocular Therapeutix Inc   2.04 $ 94.207  Millions$ 46.229  Millions
Novabay Pharmaceuticals Inc   1.99 $ 8.592  Millions$ 4.328  Millions
Ligand Pharmaceuticals Incorporated  1.98 $ 234.307  Millions$ 118.067  Millions
Clearside Biomedical Inc   1.98 $ 36.732  Millions$ 18.546  Millions
Agile Therapeutics Inc  1.95 $ 12.203  Millions$ 6.260  Millions
Novartis Ag  1.93 $ 58,030.000  Millions$ 30,122.000  Millions
Eagle Pharmaceuticals inc   1.85 $ 150.133  Millions$ 81.201  Millions
Apellis Pharmaceuticals Inc   1.84 $ 565.476  Millions$ 307.416  Millions
Aravive Inc   1.81 $ 27.180  Millions$ 15.042  Millions
Eterna Therapeutics Inc   1.79 $ 12.113  Millions$ 6.769  Millions
Pieris Pharmaceuticals Inc   1.77 $ 63.396  Millions$ 35.767  Millions

Date modified: 2022-11-28T12:27:03+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SNYR's Profile

Stock Price

SNYR's Financials

Business Description

Fundamentals

Charts & Quotes

SNYR's News

Suppliers

SNYR's Competitors

Customers & Markets

Economic Indicators

SNYR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071